Patents Assigned to Seatek Marine Biotechnology, Inc.
  • Treatment of rosacea
    Patent number: 7153826
    Abstract: Cyclic peptide antibiotics including the loloatins are effective in the treatment of rosacea, particularly when administered in conjunction with an antibiotic such as metronidazole that is effective against anaerobic bacteria.
    Type: Grant
    Filed: March 19, 2001
    Date of Patent: December 26, 2006
    Assignee: Seatek Marine Biotechnology, Inc.
    Inventor: Michael T. Kelly
  • Cyclic decapeptide antibiotics
    Patent number: 6790829
    Abstract: Several cyclic decapeptides having antibiotic activity are disclosed. The decapeptides are active against both gram positive and gram negative bacteria.
    Type: Grant
    Filed: September 29, 1998
    Date of Patent: September 14, 2004
    Assignees: SeaTek Marine Biotechnology, Inc., University of British Columbia
    Inventors: Michael T. Kelly, Raymond J. Andersen, Jeff Gerard